Effects of Preexisting Psychotropic Medication Use on a Cohort of Patients with Ischemic Stroke Outcome

Table 3

Outcome events within 365 days from the initial ischemic stroke.

Outcome events within 365 days
	Control ()	Prepsychotropic use ()	Postpsychotropic use ()	value
NIHSS	0 (0-2)	1 (0-3)	1.5 (0-6)	0.035
Delta NIHSS	1 (0-4)	3 (0-6)	5 (0-9)	0.086
Good clinical recovery	140 (82.8%)	48 (82.8%)	16 (80.0%)	0.891
mRS	1 (0-2)	2 (0-3)	2 (1-3)	0.013
MACE	18 (10.7%)	6 (10.3%)	1 (5.0%)	0.831
Myocardial infarction	2 (1.2%)	1 (1.7%)	0 (0.0%)	1.000
TIA or stroke	15 (8.9%)	5 (8.6%)	1 (5.0%)	1.000
Cardiovascular death	1 (0.6%)	0 (0.0%)	0 (0.0%)	1.000

Data are median (IQ range) and n (%); MACE: major adverse cardiovascular event. Higher numbers indicate greater improvement from discharge.